Repare Therapeutics Inc. (RPTX) Tops Q3 EPS by 57c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q3 EPS of $0.08, $0.57 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $11.62 million versus the consensus estimate of $7.5 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Walmart (WMT) PT Lowered to $130 at UBS as Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip